{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:46:46Z","timestamp":1792514806502,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00210-024-03182-9","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:03:38Z","timestamp":1717581818000},"page":"8771-8783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS\u00a0gene and efficacy of Oleuropein-conjugated iron oxide nanoparticles"],"prefix":"10.1007","volume":"397","author":[{"given":"Sedigheh","family":"Mehdinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Peymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salehzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zaefizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"3182_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-012-1225-6","volume":"15","author":"M Ahamed","year":"2013","unstructured":"Ahamed M, Alhadlaq HA, Khan MM, Akhtar MJ (2013) Selective killing of cancer cells by iron oxide nanoparticles mediated through reactive oxygen species via p53 pathway. J Nanopart Res 15:1\u201311. https:\/\/doi.org\/10.1007\/s11051-012-1225-6","journal-title":"J Nanopart Res"},{"issue":"7","key":"3182_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/medicina55070388","volume":"55","author":"F Barzegar","year":"2019","unstructured":"Barzegar F, Zaefizadeh M, Yari R, Salehzadeh A (2019) Synthesis of nano-paramagnetic oleuropein to induce KRAS over-expression: a new mechanism to inhibit AGS cancer cells. Medicina 55(7):388. https:\/\/doi.org\/10.3390\/medicina55070388","journal-title":"Medicina"},{"issue":"1","key":"3182_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/01635581.2013.741758","volume":"65","author":"A C\u00e1rdeno","year":"2013","unstructured":"C\u00e1rdeno A, S\u00e1nchez-Hidalgo M, Rosillo MA, de la Lastra CA (2013) Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human CRC cell through downregulation of HIF-1\u03b1. Nutr Cancer 65(1):147\u2013156. https:\/\/doi.org\/10.1080\/01635581.2013.741758","journal-title":"Nutr Cancer"},{"key":"3182_CR4","doi-asserted-by":"publisher","unstructured":"Charitou T, Srihari S, Lynn MA, Jarboui MA, Fasterius E, Moldovan M... Lynn DJ (2019) Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS G13D mutation. Br J Cancer 121(1):37\u201350. https:\/\/doi.org\/10.1038\/s41416-019-0477-7","DOI":"10.1038\/s41416-019-0477-7"},{"key":"3182_CR5","doi-asserted-by":"publisher","unstructured":"Fekri Kohan S, Zamani H, Salehzadeh A (2023) Antibacterial potential and cytotoxic activity of iron oxide nanoparticles conjugated with thymol (Fe3O4@Glu-Thymol) on breast cancer cells and investigating the expression of BAX, CASP8, and BCL-2 genes. Biometals 2023. https:\/\/doi.org\/10.1007\/s10534-023-00516-7","DOI":"10.1007\/s10534-023-00516-7"},{"key":"3182_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpba.2012.01.033","volume":"63","author":"S Fern\u00e1ndez-Arroyo","year":"2012","unstructured":"Fern\u00e1ndez-Arroyo S, G\u00f3mez-Mart\u00ednez A, Rocamora-Reverte L, Quirantes-Pin\u00e9 R, Segura-Carretero A, Fern\u00e1ndez-Guti\u00e9rrez A, Ferragut JA (2012) Application of nanoLC-ESI-TOF-MS for the metabolomic analysis of phenolic compounds from extra-virgin olive oil in treated colon-cancer cells. J Pharm Biomed Anal 63:128\u2013134. https:\/\/doi.org\/10.1016\/j.jpba.2012.01.033","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"3182_CR7","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1038\/s41598-018-27394-1","volume":"8","author":"R Fritsche-Guenther","year":"2018","unstructured":"Fritsche-Guenther R, Zasada C, Mastrobuoni G, Royla N, Rainer R, Ro\u00dfner F, Kempa S (2018) Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations. Scientific reports 8(1):9204. https:\/\/doi.org\/10.1038\/s41598-018-27394-1","journal-title":"Scientific reports"},{"issue":"2","key":"3182_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mnfr.201500605","volume":"60","author":"E Giner","year":"2016","unstructured":"Giner E, Recio MC, R\u00edos JL, Cerd\u00e1-Nicol\u00e1s JM, Giner RM (2016) Chemopreventive effect of oleuropein in colitis\u2010associated CRC in c57bl\/6 mice. Mol Nutr Food Res 60(2):242\u2013255. https:\/\/doi.org\/10.1002\/mnfr.201500605","journal-title":"Mol Nutr Food Res"},{"key":"3182_CR9","doi-asserted-by":"publisher","unstructured":"Hosseinkhah M, Ghasemian R, Shokrollahi F, Mojdehi SR, Noveiri MJS, Hedayati M, ... Salehzadeh A (2021) Cytotoxic potential of nickel oxide nanoparticles functionalized with glutamic acid and conjugated with thiosemicarbazide (NiO@ Glu\/TSC) against human gastric cancer cells. J Clust Sci 1\u20139. https:\/\/doi.org\/10.1007\/s10876-021-02124-2","DOI":"10.1007\/s10876-021-02124-2"},{"issue":"5","key":"3182_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.biomaterials.2011.10.080","volume":"33","author":"MI Khan","year":"2012","unstructured":"Khan MI, Mohammad A, Patil G, Naqvi SAH, Chauhan LKS, Ahmad I (2012) Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 33(5):1477\u20131488. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.10.080","journal-title":"Biomaterials"},{"issue":"10","key":"3182_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1021\/ar2000277","volume":"44","author":"FM Kievit","year":"2011","unstructured":"Kievit FM, Zhang M (2011) Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 44(10):853\u2013862. https:\/\/doi.org\/10.1021\/ar2000277","journal-title":"Acc Chem Res"},{"issue":"1","key":"3182_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.gendis.2014.10.002","volume":"2","author":"K Knickelbein","year":"2015","unstructured":"Knickelbein K, Zhang L (2015) Mutant KRAS as a critical determinant of the therapeutic response of CRC. Genes Dis 2(1):4\u201312. https:\/\/doi.org\/10.1016\/j.gendis.2014.10.002","journal-title":"Genes Dis"},{"issue":"1","key":"3182_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00775-019-01729-3","volume":"25","author":"R Kumari","year":"2020","unstructured":"Kumari R, Saini AK, Kumar A, Saini RV (2020) Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction. J Biol Inorg Chem 25(1):23\u201337. https:\/\/doi.org\/10.1007\/s00775-019-01729-3","journal-title":"J Biol Inorg Chem"},{"issue":"1","key":"3182_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1593\/neo.81006","volume":"11","author":"SH Lee","year":"2009","unstructured":"Lee SH, Lee SJ, Jung YS, Xu Y, Kang HS, Ha NC, Park BJ (2009) Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 11(1):22-IN6. https:\/\/doi.org\/10.1593\/neo.81006","journal-title":"Neoplasia"},{"issue":"7404","key":"3182_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Bardelli A (2012) Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in CRC. Nature 486(7404):532\u2013536. https:\/\/doi.org\/10.1038\/nature11156","journal-title":"Nature"},{"issue":"3","key":"3182_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.critrevonc.2012.09.014","volume":"86","author":"J Mishra","year":"2013","unstructured":"Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B, Kumar N (2013) Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol\/Hematol 86(3):232\u2013250. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.09.014","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3182_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03892-w","author":"ZM Niyaki","year":"2023","unstructured":"Niyaki ZM, Salehzadeh A, Peymani M, Zaefizadeh M (2023) Exploring the therapeutic potential of Fe3O4@ glu-oleuropein nanoparticles in targeting KRAS pathway-regulating lncRNAs in colorectal cancer cells. Biol Trace Elem Res. https:\/\/doi.org\/10.1007\/s12011-023-03892-w","journal-title":"Biol Trace Elem Res"},{"key":"3182_CR18","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"3182_CR19","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/cncr.25061","volume":"116","author":"L Santarpia","year":"2010","unstructured":"Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK (2010) Genetic alterations in the RAS\/RAF\/mitogen\u2010activated protein kinase and phosphatidylinositol 3\u2010kinase\/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer 116(12):2974\u20132983. https:\/\/doi.org\/10.1002\/cncr.25061","journal-title":"Cancer"},{"issue":"4","key":"3182_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/biof.1366","volume":"43","author":"H Shamshoum","year":"2017","unstructured":"Shamshoum H, Vlavcheski F, Tsiani E (2017) Anticancer effects of oleuropein. BioFactors 43(4):517\u2013528. https:\/\/doi.org\/10.1002\/biof.1366","journal-title":"BioFactors"},{"key":"3182_CR21","doi-asserted-by":"publisher","unstructured":"Shirmohamadi M, Eghbali E, Najjary S, Mokhtarzadeh A, Kojabad AB, Hajiasgharzadeh K\u2026 Baradaran B (2020) Regulatory mechanisms of microRNAs in CRC and CRC stem cells. J Cell Physiol 235(2):776\u2013789. https:\/\/doi.org\/10.1002\/jcp.29042","DOI":"10.1002\/jcp.29042"},{"key":"3182_CR22","doi-asserted-by":"publisher","unstructured":"Sun Q, Wang H, Xiao B, Xue D, Wang G (2022) Development and validation of a 6-gene hypoxia-related prognostic signature for cholangiocarcinoma. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.954366","DOI":"10.3389\/fonc.2022.954366"},{"issue":"3","key":"3182_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"Cancer J Clin"},{"key":"3182_CR24","doi-asserted-by":"publisher","unstructured":"Xu F, Xu H, Li Z, Huang Y, Huang X, Li Y\u2026 Lin L (2021) Glycolysis-based genes are potential biomarkers in thyroid cancer. Front Oncol 11:534838. https:\/\/doi.org\/10.3389\/fonc.2021.534838","DOI":"10.3389\/fonc.2021.534838"},{"issue":"2","key":"3182_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/17425247.2011.547470","volume":"8","author":"H Zhang","year":"2011","unstructured":"Zhang H, Wang G, Yang H (2011) Drug delivery systems for differential release in combination therapy. Expert Opin Drug Deliv 8(2):171\u2013190. https:\/\/doi.org\/10.1517\/17425247.2011.547470","journal-title":"Expert Opin Drug Deliv"},{"issue":"18","key":"3182_CR26","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2217\/fon-2018-0920","volume":"15","author":"X Zhou","year":"2019","unstructured":"Zhou X, Shang YN, Lu R, Fan CW, Mo XM (2019) High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer. Future Oncol 15(18):2093\u20132106. https:\/\/doi.org\/10.2217\/fon-2018-0920","journal-title":"Future Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03182-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03182-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03182-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:40:58Z","timestamp":1730191258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03182-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03182-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}